Bone Mesenchymal Stem Cells with Growth Factors Successfully Treat Nonunions and Delayed Unions

HSS Journal

Volumn 11, Issue 2, 2015, Pages 104-111

  Desai, Pingal ^a,b   Hasan, Saad Mumtaz ^a   Zambrana, Lester ^a   Hegde, Vishal ^a   Saleh, Anas ^b   Cohn, Matthew R ^a   Lane, Joseph M ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

BMAC (concentrated autogenous iliac crest bone marrow aspirate); bone morphogenic protein; delayed union; demineralized bone matrix; modified Hernigou technique; nonunion

Indexed keywords

EID: 84933179222     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-015-9432-1     Document Type: Article

References (26)

1. Agarwal R, Williams K, Umscheid CA, Welch WC. Osteoinductive bone graft substitutes for lumbar fusion: A systematic review. J Neurosurg Spine. 2009; 11(6): 729-740.
2. Black DM, Bauer DC, Schwartz AV, Cummings SR, Rosen CJ. Continuing bisphosphonate treatment for osteoporosis–for whom and for how long? N Engl J Med. 2012; 366(22): 2051-2053.
3. Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop Relat Res. 1985;(200)(200):125-141.
4. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J. 2011; 11(6): 471-491.
5. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991;(266)(266):259–270.
6. Dahabreh Z, Calori GM, Kanakaris NK, Nikolaou VS, Giannoudis PV. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int Orthop. 2009; 33(5): 1407-1414.
7. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999; 14(7): 1115-1122.
8. dos Reis FB, Faloppa F, Fernandes HJ, Albertoni WM, Stahel PF. Outcome of diaphyseal forearm fracture-nonunions treated by autologous bone grafting and compression plating. Ann Surg Innov Res. 2009;3:5-1164-3-5.
9. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001; 83-A(Suppl 1(Pt 2)): S151-S158.
10. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: The diamond concept. Injury. 2007; 38(Suppl 4): S3-S6.
11. Healey JH, Zimmerman PA, McDonnell JM, Lane JM. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res. 1990;(256)(256):280–285.
12. Hernigou P. Growth factors released from bone marrow are promising tools in orthopedic surgery. Rev Rhum Engl Ed. 1998; 65(2): 79-84.
13. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005; 87(7): 1430-1437.
14. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg (Br). 2005; 87(7): 896-902.
15. Hierholzer C, Sama D, Toro JB, Peterson M, Helfet DL. Plate fixation of ununited humeral shaft fractures: Effect of type of bone graft on healing. J Bone Joint Surg Am. 2006; 88(7): 1442-1447.
16. Lane JM. Bone morphogenic protein science and studies. J Orthop Trauma. 2005; 19(10 Suppl): S17-S22.
17. Liebergall M, Schroeder J, Mosheiff R, et al. Stem cell-based therapy for prevention of delayed fracture union: A randomized and prospective preliminary study. Mol Ther. 2013; 21(8): 1631-1638.
18. Lindholm TS, Urist MR. A quantitative analysis of new bone formation by induction in compositive grafts of bone marrow and bone matrix. Clin Orthop Relat Res. 1980;(150)(150):288–300.
19. Mollon B, da Silva V, Busse JW, Einhorn TA, Bhandari M. Electrical stimulation for long-bone fracture-healing: A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2008; 90(11): 2322-2330.
20. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int. 1995; 56(2): 123-129.
21. Salama R, Weissman SL. The clinical use of combined xenografts of bone and autologous red marrow. A preliminary report. J Bone Joint Surg (Br). 1978; 60(1): 111-115.
22. Tiedeman JJ, Connolly JF, Strates BS, Lippiello L. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. an experimental study in dogs. Clin Orthop Relat Res. 1991;(268)(268):294–302.
23. Veillette CJ, McKee MD. Growth factors–BMPs, DBMs, and buffy coat products: Are there any proven differences amongst them? Injury. 2007; 38(Suppl 1): S38-S48.
24. Wilkins RM, Kelly CM. The effect of allomatrix injectable putty on the outcome of long bone applications. Orthopedics. 2003; 26(5 Suppl): s567-s570.
25. Wiss DA, Stetson WB. Tibial nonunion: Treatment alternatives. J Am Acad Orthop Surg. 1996; 4(5): 249-257.
26. Ziran B, Cheung S, Smith W, Westerheide K. Comparative efficacy of 2 different demineralized bone matrix allografts in treating long-bone nonunions in heavy tobacco smokers. Am J Orthop (Belle Mead NJ). 2005; 34(7): 329-332.